OROT, the innovation hub of the JGH and the CIUSSS, is linking entrepreneurs with healthcare experts to develop new products for better care.
COVID@HOME, a new program, allows certain COVID-19 patients to be discharged from the JGH and return to home to a virtual ward.
A pace-setting JGH clinic is providing care and support to patients with rare blood cancers, while raising awareness and promoting research.
Dr. Susan Kahn, a Senior Investigator in the Lady Davis Institute, has been renewed as a Tier 1 Canada Research Chair in Venous Thromboembolism.
A global study, in which the LDI participated, has identified a specific gene variant that protects against severe infection by COVID-19.
In the high-tech environment of telehealth, new skills and techniques are being developed to maintain trust and intimacy between healthcare users and providers.
Despite its setbacks during the COVID-19 pandemic, The JGH Auxiliary is embarking on new efforts to keep raising funds for better patient care.
Many Hope & Cope volunteers were troubled by not being allowed to see cancer patients in person during the pandemic, but now those ties are being re-established.
Looking for information about blood clots, deep vein thrombosis and pulmonary embolisms? A new JGH website has the information you need.